Docusign, Inc. filings document the public-company record for a cloud software business built around Intelligent Agreement Management, e-signature and contract lifecycle management. Its 8-K reports cover operating results, financial-condition updates, share repurchase authorization disclosures and material governance events, including appointments to the board of directors and related independence determinations.
Proxy materials provide formal disclosure on board structure, director matters, executive compensation, equity awards and stockholder meeting governance. Together, the filings describe Docusign’s reporting obligations, capital-return actions, governance framework and compensation practices alongside the operating performance of its agreement-management software business.
DOCUSIGN, INC. director Michael George Rosenbaum exercised restricted stock units into common shares. He acquired 522 shares of common stock through the conversion of 522 restricted stock units at a reported price of $0.0000 per share, with no shares sold in these transactions.
Following the exercise, he directly holds 1,566 shares of common stock and 4,699 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock, and the units vest in twelve equal quarterly installments over three years, subject to continued service.
Docusign, Inc. reported the results of its 2026 Annual Meeting of Stockholders. Holders of 169,169,645 shares of common stock, representing approximately 87% of shares entitled to vote, were present, establishing a quorum.
Stockholders elected James Beer, Cain A. Hayes and Allan Thygesen to three-year terms ending at the 2029 annual meeting. They also ratified PricewaterhouseCoopers LLP as independent registered accounting firm for the fiscal year ending January 31, 2027.
On an advisory, non-binding basis, stockholders approved named executive officer compensation and supported holding future advisory votes on this compensation every year. A stockholder proposal requesting a report on risks of non-fiduciary executive compensation metrics did not receive approval.
DocuSign director Enrique T. Salem reported equity compensation activity. He received a grant of 4,384 restricted stock units (RSUs), each representing one share of common stock, vesting in equal quarterly installments over one year, tied to continued service.
On a separate date, he exercised 729 RSUs into 729 shares of common stock at no exercise price and did not report any same-day sale. After these transactions, he directly holds 167,318 shares of DocuSign common stock.
DOCUSIGN, INC. director Teresa Briggs reported a mix of equity compensation and routine trading activity. She received a grant of 4,384 restricted stock units, each representing one share of common stock, which will vest in equal quarterly installments over one year, subject to continued service. On the same filing, she exercised 729 RSUs into common stock and sold 365 common shares at $50.04 per share in an open-market transaction executed under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, she holds 10,263 common shares directly.
DOCUSIGN, INC. director Mary Agnes Wilderotter reported routine equity compensation and estate-planning moves. She received a grant of 4,384 restricted stock units (RSUs) on June 1, 2026, each representing one share of common stock, vesting in equal quarterly installments over one year subject to continued service.
On May 29, 2026, she exercised 729 RSUs into 729 shares of common stock, bringing her directly held common stock to 3,199 shares. Earlier, on April 2, 2026, she made a bona fide gift of 57,333 shares of common stock to the Wilderotter Family Trust for no consideration. She serves as trustee, and she and her immediate family are the sole beneficiaries, so she continues to be the beneficial owner of those trust-held shares.
DOCUSIGN director Peter Solvik reported equity compensation and a routine option-style exercise. On June 1, 2026, he received a grant of 4,384 Restricted Stock Units, each representing one share of common stock, vesting quarterly over one year starting on that date, subject to continued service.
On May 29, 2026, Solvik exercised 729 RSUs for 729 shares of common stock at an exercise price of $0.00, bringing his directly held common stock to 8,970 shares. The filing also lists indirect holdings, including 6,458 shares held by his spouse, 65,558 shares held by children’s trusts, 120,253 shares held by a trust, and 3 shares held by a family partnership. No open-market purchases or sales were reported.
DOCUSIGN, INC. director Cain A. Hayes reported routine equity compensation activity. On June 1, 2026, Hayes received a grant of 4,384 Restricted Stock Units (RSUs), each representing a right to one share of common stock, vesting quarterly over one year subject to continued service.
On May 29, 2026, Hayes exercised a prior RSU award, converting 729 RSUs into an equal number of common shares. Following these transactions, Hayes directly holds 15,717 shares of common stock and 4,384 RSUs, with no reported stock sales in this filing.
DocuSign director Irving Blake reported equity compensation activity. Blake received a grant of 4,384 restricted stock units (RSUs), each representing a contingent right to one share of DocuSign common stock. These RSUs have a vest commencement date of June 1, 2026 and will vest in equal quarterly installments over one year, with the final tranche vesting on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, subject to continued service.
On May 29, 2026, 729 RSUs were exercised and converted into 729 shares of common stock, reflecting a derivative exercise rather than an open-market purchase. Following this transaction, Blake directly held 26,093 shares of DocuSign common stock. The RSUs do not expire; they either vest or are canceled before vesting, so these transactions primarily reflect routine director compensation and vesting mechanics.
DocuSign director James A. Beer reported mixed equity activity, including a small open-market sale and routine equity awards. He sold 450 shares of common stock on June 2, 2026 at $55.04 per share in an open-market transaction under a pre-arranged Rule 10b5-1 plan, leaving him with 15,036 directly held shares. On May 29, 2026, 729 Restricted Stock Units (RSUs) converted into 729 shares of common stock as they vested. He also holds 5,543 shares indirectly through a trust. On June 1, 2026, he received a grant of 4,384 RSUs, each representing a right to one share of common stock, scheduled to vest in equal quarterly installments over one year, subject to continued service and the timing of the company’s next annual stockholder meeting.
DOCUSIGN, INC. director Anna Marrs reported a mix of equity compensation and routine trading activity. She sold 365 shares of common stock on June 2, 2026 at $55.04 per share under a pre-arranged Rule 10b5-1 trading plan, and held 12,615 common shares afterward.
On May 29, 2026, 729 Restricted Stock Units (RSUs) were exercised into 729 common shares, fully settling that RSU lot. On June 1, 2026, she received a grant of 4,384 RSUs, each representing one future share of common stock, vesting quarterly over one year based on continued service.